Could a simple device help curb malaria in children?

NCT ID NCT07712263

First seen Jul 17, 2026 · Last updated Jul 23, 2026 · Updated 2 times

Summary

This study tests whether a device called the Guardian spatial emanator, which releases mosquito-repelling ingredients into the air, can be effectively added to an existing program that distributes antibiotics to children in Niger. The goal is to see if this integrated approach can reduce malaria-related clinic visits in children under 5. Researchers will measure how many households receive and correctly use the devices, and whether the community accepts them.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Guardian spatial emanator (a device that releases volatile ingredients to repel mosquitoes)
What this could lead to
If successful, this approach could provide a scalable, low-cost way to prevent malaria in high-transmission areas without relying solely on bed nets or drugs.
What could go wrong
This is an implementation study, not a controlled efficacy trial, so it may not prove the device directly reduces malaria cases. Real-world factors like incorrect placement or low acceptance could limit impact.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALARIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Program National de Santé Oculaire

    Niamey, Niger

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.